Tumor Protein p73 (TP73) DNA-Binding ELISA Kit
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
p73 DNA-Binding ELISA Kit is an ELISA Kit against p73.
Documents del producto
Product specifications
| Category | ELISA Kits |
| Immunogen Target | Tumor Protein p73 (TP73) |
| Reactivity | Human, Mouse, Rat |
| Detection Method | Colorimetric |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Size 1 | 96 tests |
| Tested Applications | ELISA |
| Availability | Shipped within 1-2 weeks. The validity for this kit is at least 6 months |
| Storage | Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual. |
| Dry Ice | No |
| UniProt ID | O15350 |
| Gene ID | 7161 |
| OMIM | 601990 |
| Background | Elisa kits for TP73 |
| Status | RUO |
| Note | Validity: 6 months. This product is for research use only. The range and sensitivity is subject to change. Please contact us for the latest product information. For accurate results, sample concentrations must be diluted to mid-range of the kit. If you require a specific range, please contact us in advance or write your request in your order comments. Please note that our ELISA and CLIA kits are optimised for detection of native samples, rather than recombinant proteins. We are unable to guarantee detection of recombinant proteins, as they may have different sequences or tertiary structures to the native protein. |
Descripción
Related Products
Mouse TP73 (Tumor Protein p73) ELISA Kit
Ver Producto
TP73 antibody
Ver Producto
TP73 (pY99) Antibody
TP73 (pY99) Antibody is a Rabbit Polyclonal antibody against TP73 (pY99). This gene encodes a member of the p53 family of transcription factors involved in cellular responses to stress and development. It maps to a region on chromosome 1p36 that is frequently deleted in neuroblastoma and other tumors, and thought to contain multiple tumor suppressor genes. The demonstration that this gene is monoallelically expressed (likely from the maternal allele), supports the notion that it is a candidate gene for neuroblastoma. Many transcript variants resulting from alternative splicing and/or use of alternate promoters have been found for this gene, but the biological validity and the full-length nature of some variants have not been determined.
Ver Producto